EZH2 and Burkitt lymphoma: In an in vivo study, the liver of hu-PBMC-CDX mouse showed less tumor cell infiltration compared to the control (Figure 4B), along with decreased expression levels of EZH2 and c-MYC, indicating that dEZH2 effectively suppresses Burkitt’s lymphoma (Figure 4D).